Literature DB >> 23370234

2012 FDA drug approvals.

Asher Mullard.   

Abstract

Mesh：

Year:  2013        PMID： 23370234     DOI： 10.1038/nrd3946

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  28 in total

1.  Debate: Molecular cardiac imaging is ready for the prime time con between wishful thinking and reality.

Authors:  Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

2.  pH-Responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins.

Authors:  Michael C Koetting; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2014-05-20       Impact factor: 5.875

3.  Construction strategies for developing expression vectors for recombinant monoclonal antibody production in CHO cells.

Authors:  Yan-Mei Li; Zheng-Wei Tian; Dan-Hua Xu; Xiao-Yin Wang; Tian-Yun Wang
Journal:  Mol Biol Rep       Date:  2018-09-06       Impact factor: 2.316

4.  Clinical development success rates for investigational drugs.

Authors:  Michael Hay; David W Thomas; John L Craighead; Celia Economides; Jesse Rosenthal
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

5.  Acquiring orphans.

Authors:  Rogier Rooswinkel; Geert-Jan Mulder; Sander van Deventer
Journal:  Nat Biotechnol       Date:  2014-03       Impact factor: 54.908

Review 6.  Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.

Authors:  Mark J Niciu; Daniel C Mathews; Allison C Nugent; Dawn F Ionescu; Maura L Furey; Erica M Richards; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2013-12-18       Impact factor: 6.505

7.  Two decades of publishing excellence in pharmaceutical biotechnology.

Authors:  David B Volkin; Susan Hershenson; Rodney J Y Ho; Susumu Uchiyama; Gerhard Winter; John F Carpenter
Journal:  J Pharm Sci       Date:  2014-12-01       Impact factor: 3.534

8.  Biomarkers in mood disorders research: developing new and improved therapeutics.

Authors:  Mark J Niciu; Daniel C Mathews; Dawn F Ionescu; Erica M Richards; Maura L Furey; Peixiong Yuan; Allison C Nugent; Ioline D Henter; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Rev Psiquiatr Clin       Date:  2014       Impact factor: 0.909

9.  pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery.

Authors:  Michael Clinton Koetting; Joseph Frank Guido; Malvika Gupta; Annie Zhang; Nicholas A Peppas
Journal:  J Control Release       Date:  2015-12-02       Impact factor: 9.776

10.  Direct Cytosolic Delivery of Proteins through Coengineering of Proteins and Polymeric Delivery Vehicles.

Authors:  Yi-Wei Lee; David C Luther; Ritabrita Goswami; Taewon Jeon; Vincent Clark; James Elia; Sanjana Gopalakrishnan; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2020-02-25       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.